Cite

HARVARD Citation

    Buijs, M. et al. (2013). Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 119 (5), pp. 1042-1049. [Online]. 
  
Back to record